{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:22:27Z","timestamp":1794446547056,"version":"4.9.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:00:00Z","timestamp":1794441600000},"content-version":"vor","delay-in-days":132,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Idiopathic pulmonary fibrosis (IPF) is a paradigmatic aging-related lung disorder. In this retrospective cohort study, we evaluated 101 treatment-na\u00efve patients at diagnosis (T0) and a subgroup (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200931) after one year of antifibrotic therapy (T1). Analyses included leukocyte telomere length (LTL), DNA methylation age [DNAmAge assessed by Horvath, Levine (PhenoAge), Skin &amp; Blood, Hannum, BLUP, Elastic Net (EN), and a 5-CpG panel], age acceleration (AgeAcc), and genetic susceptibility. At T1, LTL was independently predicted by baseline LTL (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0004) and treatment duration (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0056). Longitudinally, \u0394LTL increased in nintedanib- versus pirfenidone-treated patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0402) and with treatment duration (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0233). DNAmAge modestly increased with chronological aging across all clocks, while AgeAcc remained stable, decreasing at follow-up (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0435) and higher in males (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0204). Genetic analyses on 17 IPF-associated SNPs confirmed enrichment of established risk variants, including\n                    <jats:italic>MUC5B<\/jats:italic>\n                    and\n                    <jats:italic>DPP9<\/jats:italic>\n                    , and identified an association between higher genetic burden and lower forced vital capacity (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0136). Extending this approach, genome-wide imputation enabled polygenic risk score (PRS) analysis, revealing significant case\u2013control differences and discrimination (AUC up to 0.79), supporting a measurable polygenic contribution to disease susceptibility. These findings highlight the added value of integrating telomeric, epigenetic, and genome-wide genetic burden\u2014captured through PRS\u2014for improved risk stratification in IPF.\n                  <\/jats:p>","DOI":"10.1038\/s41514-026-00434-1","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:52:15Z","timestamp":1783101135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Telomere integrity, epigenetic aging, and genetic burden shape biological aging trajectories in idiopathic pulmonary fibrosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Manuela","family":"Campisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Liviero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Tamiazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Balestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"434_CR1","unstructured":"Ageing and health. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health."},{"key":"434_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/acel.12601","volume":"16","author":"SS Khan","year":"2017","unstructured":"Khan, S. S., Singer, B. D. & Vaughan, D. E. Molecular and physiological manifestations and measurement of aging in humans. Aging Cell. 16, 624\u2013633 (2017).","journal-title":"Aging Cell."},{"key":"434_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: An expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"434_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","volume":"378","author":"DJ Lederer","year":"2018","unstructured":"Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 378, 1811\u20131823 (2018).","journal-title":"N. Engl. J. Med."},{"key":"434_CR5","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu, G. et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 198, e44\u2013e68 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George, P. M., Wells, A. U. & Jenkins, R. G. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir. Med. 8, 807\u2013815 (2020).","journal-title":"Lancet Respir. Med."},{"key":"434_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s41030-019-00108-2","volume":"6","author":"RH Zou","year":"2020","unstructured":"Zou, R. H., Kass, D. J., Gibson, K. F. & Lindell, K. O. The role of palliative care in reducing symptoms and improving quality of life for patients with idiopathic pulmonary fibrosis: A review. Pulm. Ther. 6, 35\u201346 (2020).","journal-title":"Pulm. Ther."},{"key":"434_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.amjms.2019.02.008","volume":"357","author":"S Gulati","year":"2019","unstructured":"Gulati, S. & Thannickal, V. J. The aging lung and idiopathic pulmonary fibrosis. Am. J. Med. Sci. 357, 384\u2013389 (2019).","journal-title":"Am. J. Med. Sci."},{"key":"434_CR9","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1164\/rccm.201904-0717ST","volume":"199","author":"PD Blanc","year":"2019","unstructured":"Blanc, P. D. et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. Am. J. Respir. Crit. Care Med.199, 1312\u20131334 (2019).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"434_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/10937404.2022.2131663","volume":"25","author":"A Pauchet","year":"2022","unstructured":"Pauchet, A. et al. Idiopathic pulmonary fibrosis: What do we know about the role of occupational and environmental determinants? a systematic literature review and meta-analysis. J. Toxicol. Environ. Health, Part B 25, 372\u2013392 (2022).","journal-title":"J. Toxicol. Environ. Health, Part B"},{"key":"434_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81591-z","volume":"11","author":"Y Park","year":"2021","unstructured":"Park, Y., Ahn, C. & Kim, T.-H. Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses. Sci. Rep. 11, 4318 (2021).","journal-title":"Sci. Rep."},{"key":"434_CR12","doi-asserted-by":"publisher","first-page":"16481","DOI":"10.3390\/ijms242216481","volume":"24","author":"S Gandhi","year":"2023","unstructured":"Gandhi, S., Tonelli, R., Murray, M., Samarelli, A. V. & Spagnolo, P. Environmental causes of idiopathic pulmonary fibrosis. Int. J. Mol. Sci. 24, 16481 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"434_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107738","volume":"231","author":"Y Park","year":"2024","unstructured":"Park, Y. et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A case-control study. Respir. Med. 231, 107738 (2024).","journal-title":"Respir. Med."},{"key":"434_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1513\/AnnalsATS.202404-382OC","volume":"22","author":"C Sack","year":"2025","unstructured":"Sack, C. et al. Long-term air pollution exposure and severity of idiopathic pulmonary fibrosis: Data from the idiopathic pulmonary fibrosis prospective outcomes (IPF-PRO) registry. Ann. Am. Thorac. Soc. 22, 378\u2013386 (2025).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"434_CR15","doi-asserted-by":"publisher","first-page":"13051","DOI":"10.1073\/pnas.0804280105","volume":"105","author":"JK Alder","year":"2008","unstructured":"Alder, J. K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. 105, 13051\u201313056 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"434_CR16","doi-asserted-by":"publisher","first-page":"e86704","DOI":"10.1172\/jci.insight.86704","volume":"1","author":"RP Naikawadi","year":"2016","unstructured":"Naikawadi, R. P. et al. Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis. JCI Insight. 1, e86704 (2016).","journal-title":"JCI Insight."},{"key":"434_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S2213-2600(20)30364-7","volume":"9","author":"A Duckworth","year":"2021","unstructured":"Duckworth, A. et al. Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study. Lancet Respir. Med. 9, 285\u2013294 (2021).","journal-title":"Lancet Respir. Med."},{"key":"434_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"EH Blackburn","year":"2015","unstructured":"Blackburn, E. H., Epel, E. S. & Lin, J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 350, 1193\u20131198 (2015).","journal-title":"Science."},{"key":"434_CR19","first-page":"28","volume":"14","author":"MA Shammas","year":"2011","unstructured":"Shammas, M. A. Telomeres, lifestyle, cancer, and aging. Curr. Opin. Clin. Nutr. Metab. Care. 14, 28\u201334 (2011).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"434_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2609","volume":"45","author":"TE Fingerlin","year":"2013","unstructured":"Fingerlin, T. E. et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 45, 613\u2013620 (2013).","journal-title":"Nat. Genet."},{"key":"434_CR21","doi-asserted-by":"publisher","first-page":"9293","DOI":"10.1073\/pnas.0911494107","volume":"107","author":"D Levy","year":"2010","unstructured":"Levy, D. et al. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc. Natl. Acad. Sci. 107, 9293\u20139298 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"434_CR22","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","volume":"48","author":"CA Newton","year":"2016","unstructured":"Newton, C. A. et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur. Respir. J. 48, 1710\u20131720 (2016).","journal-title":"Eur. Respir. J."},{"key":"434_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00408-025-00830-6","volume":"203","author":"C Dahlqvist","year":"2025","unstructured":"Dahlqvist, C. et al. Use of telomere length as a biomarker in idiopathic pulmonary fibrosis. Lung. 203, 78 (2025).","journal-title":"Lung."},{"key":"434_CR24","doi-asserted-by":"publisher","first-page":"e10680","DOI":"10.1371\/journal.pone.0010680","volume":"5","author":"Leon","year":"2010","unstructured":"Leon et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLOS ONE. 5, e10680 (2010).","journal-title":"PLOS ONE."},{"key":"434_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156 (2013).","journal-title":"Genome Biol."},{"key":"434_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","volume":"49","author":"G Hannum","year":"2013","unstructured":"Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell. 49, 359\u2013367 (2013).","journal-title":"Mol. Cell."},{"key":"434_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0656-7","volume":"11","author":"PD Fransquet","year":"2019","unstructured":"Fransquet, P. D., Wrigglesworth, J., Woods, R. L., Ernst, M. E. & Ryan, J. The epigenetic clock as a predictor of disease and mortality risk: A systematic review and meta-analysis. Clin. Epigen. 11, 62 (2019).","journal-title":"Clin. Epigen."},{"key":"434_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/gerona\/glz099","volume":"75","author":"J Ryan","year":"2020","unstructured":"Ryan, J., Wrigglesworth, J., Loong, J., Fransquet, P. D. & Woods, R. L. A systematic review and meta-analysis of environmental, lifestyle, and health factors associated with DNA methylation age. J. Gerontol. A Biol. Sci. Med Sci. 75, 481\u2013494 (2020).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"434_CR29","doi-asserted-by":"publisher","first-page":"101348","DOI":"10.1016\/j.arr.2021.101348","volume":"69","author":"L Oblak","year":"2021","unstructured":"Oblak, L., van der Zaag, J., Higgins-Chen, A. T., Levine, M. E. & Boks, M. P. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Res. Rev. 69, 101348 (2021).","journal-title":"Ageing Res. Rev."},{"key":"434_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s43018-024-00745-w","volume":"5","author":"JL Guida","year":"2024","unstructured":"Guida, J. L. et al. Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetime Cohort. Nat. Cancer 5, 731\u2013741 (2024).","journal-title":"Nat. Cancer"},{"key":"434_CR31","doi-asserted-by":"publisher","first-page":"117255","DOI":"10.1016\/j.bone.2024.117255","volume":"189","author":"G Zhu","year":"2024","unstructured":"Zhu, G., Guo, B. & Liang, J. Evaluating the role of biological age in osteoporosis risk among middle-aged and older adults: A nationwide perspective. Bone. 189, 117255 (2024).","journal-title":"Bone."},{"key":"434_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-025-01872-6","volume":"17","author":"Y Zou","year":"2025","unstructured":"Zou, Y., Huang, J., Tang, X. & Xu, J. Associations between five indicators of epigenetic age acceleration and all-cause and cause-specific mortality among US adults aged 50 years and older. Clin. Epigen. 17, 66 (2025).","journal-title":"Clin. Epigen."},{"key":"434_CR33","doi-asserted-by":"publisher","first-page":"L456","DOI":"10.1152\/ajplung.00171.2024","volume":"328","author":"DB Kurbanov","year":"2025","unstructured":"Kurbanov, D. B. et al. Epigenetic age acceleration in idiopathic pulmonary fibrosis revealed by DNA methylation clocks. Am. J. Physiol. Lung Cell Mol. Physiol. 328, L456\u2013L462 (2025).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"434_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King","year":"2014","unstructured":"King, T. E. et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083\u20132092 (2014).","journal-title":"N. Engl. J. Med."},{"key":"434_CR35","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. N. Engl. J. Med. 370, 2071\u20132082 (2014).","journal-title":"N. Engl. J. Med."},{"key":"434_CR36","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1183\/09031936.00174914","volume":"45","author":"L Wollin","year":"2015","unstructured":"Wollin, L. et al. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Eur. Respir. J. 45, 1434\u20131445 (2015).","journal-title":"Eur. Respir. J."},{"key":"434_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155899","volume":"154","author":"H Layoun","year":"2022","unstructured":"Layoun, H. et al. Pirfenidone mitigates TGF-\u03b21-mediated fibrosis in an idiopathic inflammatory myositis-associated interstitial lung disease model. Cytokine 154, 155899 (2022).","journal-title":"Cytokine"},{"key":"434_CR38","first-page":"1911","volume":"17","author":"A Zhavoronkov","year":"2025","unstructured":"Zhavoronkov, A., Wilczok, D., Ren, F. & Galkin, F. Age-related diseases as a testbed for anti-aging therapeutics: the case of idiopathic pulmonary fibrosis. Aging. 17, 1911\u20131928 (2025).","journal-title":"Aging."},{"key":"434_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrd.2017.170","volume":"16","author":"AL Mora","year":"2017","unstructured":"Mora, A. L., Rojas, M., Pardo, A. & Selman, M. Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. Nat. Rev. Drug Discov. 16, 755\u2013772 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"434_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/cells14030222","volume":"14","author":"AL Torres-Machorro","year":"2025","unstructured":"Torres-Machorro, A. L. et al. Update of aging hallmarks in idiopathic pulmonary fibrosis. Cells. 14, 222 (2025).","journal-title":"Cells."},{"key":"434_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2023.139362","volume":"337","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Low-level ambient sulfur dioxide exposure and genetic susceptibility associated with incidence of idiopathic pulmonary fibrosis: A national prospective cohort study. Chemosphere. 337, 139362 (2023).","journal-title":"Chemosphere."},{"key":"434_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82182-8","volume":"11","author":"MJ Song","year":"2021","unstructured":"Song, M. J. et al. A nationwide population-based study of incidence and mortality of lung cancer in idiopathic pulmonary fibrosis. Sci. Rep. 11, 2596 (2021).","journal-title":"Sci. Rep."},{"key":"434_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","volume":"200","author":"CA Newton","year":"2019","unstructured":"Newton, C. A. et al. Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 200, 336\u2013347 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR44","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.3390\/jcm11236893","volume":"11","author":"A Mulet","year":"2022","unstructured":"Mulet, A. & Signes-Costa, J. Idiopathic pulmonary fibrosis and telomeres. J. Clin. Med. 11, 6893 (2022).","journal-title":"J. Clin. Med."},{"key":"434_CR45","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.healun.2025.10.028","volume":"45","author":"AM Courtwright","year":"2026","unstructured":"Courtwright, A. M. et al. ISHLT consensus statement on short telomere syndrome and lung transplantation. J. Heart Lung Transpl. 45, e83\u2013e103 (2026).","journal-title":"J. Heart Lung Transpl."},{"key":"434_CR46","doi-asserted-by":"publisher","first-page":"240259","DOI":"10.1183\/20734735.0259-2024","volume":"21","author":"A Denis","year":"2025","unstructured":"Denis, A., Tsiri, P., Guiot, J. & Tzouvelekis, A. A new era in the treatment of progressive fibrosing interstitial lung diseases. Breathe (Sheff.) 21, 240259 (2025).","journal-title":"Breathe (Sheff.)"},{"key":"434_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05207-8","volume":"13","author":"H-J Cho","year":"2022","unstructured":"Cho, H.-J. et al. Nintedanib induces senolytic effect via STAT3 inhibition. Cell Death Dis. 13, 760 (2022).","journal-title":"Cell Death Dis."},{"key":"434_CR48","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","volume":"36","author":"CA Newton","year":"2017","unstructured":"Newton, C. A. et al. Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival. J. Heart Lung Transpl. 36, 845\u2013853 (2017).","journal-title":"J. Heart Lung Transpl."},{"key":"434_CR49","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","volume":"374","author":"DM Townsley","year":"2016","unstructured":"Townsley, D. M. et al. Danazol treatment for telomere diseases. N. Engl. J. Med. 374, 1922\u20131931 (2016).","journal-title":"N. Engl. J. Med."},{"key":"434_CR50","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41556-022-00991-z","volume":"24","author":"A Lanna","year":"2022","unstructured":"Lanna, A. et al. An intercellular transfer of telomeres rescues T cells from senescence and promotes long-term immunological memory. Nat. Cell Biol. 24, 1461\u20131474 (2022).","journal-title":"Nat. Cell Biol."},{"key":"434_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.832411","volume":"9","author":"S Pavanello","year":"2022","unstructured":"Pavanello, S. et al. DNA methylation - and telomere - based biological age estimation as markers of biological aging in donors kidneys. Front Med (Lausanne). 9, 832411 (2022).","journal-title":"Front Med (Lausanne)."},{"key":"434_CR52","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1007\/s11357-025-01580-2","volume":"47","author":"M Campisi","year":"2025","unstructured":"Campisi, M. et al. Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life. GeroScience. 47, 4253\u20134290 (2025).","journal-title":"GeroScience."},{"key":"434_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 10, 573\u2013591 (2018).","journal-title":"Aging (Albany NY)."},{"key":"434_CR54","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.18632\/aging.101508","volume":"10","author":"S Horvath","year":"2018","unstructured":"Horvath, S. et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging 10, 1758\u20131775 (2018).","journal-title":"Aging"},{"key":"434_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0667-1","volume":"11","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Med. 11, 54 (2019).","journal-title":"Genome Med."},{"key":"434_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.fsigen.2015.05.001","volume":"17","author":"R Zbie\u0107-Piekarska","year":"2015","unstructured":"Zbie\u0107-Piekarska, R. et al. Development of a forensically useful age prediction method based on DNA methylation analysis. Forensic Sci. Int.: Genet. 17, 173\u2013179 (2015).","journal-title":"Forensic Sci. Int.: Genet."},{"key":"434_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-023-00975-y","volume":"22","author":"M Campisi","year":"2023","unstructured":"Campisi, M. et al. The effect of high polycyclic aromatic hydrocarbon exposure on biological aging indicators. Environ. Health. 22, 27 (2023).","journal-title":"Environ. Health."},{"key":"434_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67622-1","volume":"10","author":"S Pavanello","year":"2020","unstructured":"Pavanello, S. et al. The biological age of the heart is consistently younger than chronological age. Sci. Rep. 10, 10752 (2020).","journal-title":"Sci. Rep."},{"key":"434_CR59","doi-asserted-by":"publisher","first-page":"690312","DOI":"10.3389\/fmed.2021.690312","volume":"8","author":"M Campisi","year":"2021","unstructured":"Campisi, M., Liviero, F., Maestrelli, P., Guarnieri, G. & Pavanello, S. DNA methylation-based age prediction and telomere length reveal an accelerated aging in induced sputum cells compared to blood leukocytes: A pilot study in COPD patients. Front. Med. 8, 690312 (2021).","journal-title":"Front. Med."},{"key":"434_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1354025","volume":"16","author":"M Campisi","year":"2024","unstructured":"Campisi, M. et al. Mitigating cellular aging and enhancing cognitive functionality: visual arts-mediated cognitive activation therapy in neurocognitive disorders. Front Aging Neurosci. 16, 1354025 (2024).","journal-title":"Front Aging Neurosci."},{"key":"434_CR61","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3390\/ijerph16173074","volume":"16","author":"S Pavanello","year":"2019","unstructured":"Pavanello, S., Campisi, M., Tona, F., Lin, C. D. & Iliceto, S. Exploring epigenetic age in response to intensive relaxing training: a pilot study to slow down biological age. Int. J. Environ. Res. Public Health 16, 3074 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"434_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.18632\/aging.101385","volume":"10","author":"M Sp\u00f3lnicka","year":"2018","unstructured":"Sp\u00f3lnicka, M. et al. Modified aging of elite athletes revealed by analysis of epigenetic age markers. Aging (Albany NY). 10, 241\u2013252 (2018).","journal-title":"Aging (Albany NY)."},{"key":"434_CR63","doi-asserted-by":"publisher","first-page":"10639","DOI":"10.3390\/ijerph182010639","volume":"18","author":"M Carugno","year":"2021","unstructured":"Carugno, M. et al. Can night shift work affect biological age? hints from a cross-sectional study on hospital female nurses. Int. J. Environ. Res. Public Health. 18, 10639 (2021).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"434_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2025.112409","volume":"369","author":"E Paparazzo","year":"2025","unstructured":"Paparazzo, E. et al. Reproducibility and validation of a targeted and flexible epigenetic clock for forensic applications. Forensic Sci. Int. 369, 112409 (2025).","journal-title":"Forensic Sci. Int."},{"key":"434_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/epigenomes9020019","volume":"9","author":"E Pozdysheva","year":"2025","unstructured":"Pozdysheva, E. et al. Association of model-predicted epigenetic age and female infertility. Epigenomes. 9, 19 (2025).","journal-title":"Epigenomes."},{"key":"434_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110267","volume":"311","author":"HC Dias","year":"2020","unstructured":"Dias, H. C. et al. DNA methylation age estimation in blood samples of living and deceased individuals using a multiplex SNaPshot assay. Forensic Sci. Int. 311, 110267 (2020).","journal-title":"Forensic Sci. Int."},{"key":"434_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fsigen.2018.09.010","volume":"38","author":"S-E Jung","year":"2019","unstructured":"Jung, S.-E. et al. DNA methylation of the ELOVL2, FHL2, KLF14, C1orf132\/MIR29B2C, and TRIM59 genes for age prediction from blood, saliva, and buccal swab samples. Forensic Sci. Int. Genet 38, 1\u20138 (2019).","journal-title":"Forensic Sci. Int. Genet"},{"key":"434_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9175806","volume":"2017","author":"A Guillaumet-Adkins","year":"2017","unstructured":"Guillaumet-Adkins, A. et al. Epigenetics and oxidative stress in aging. Oxid. Med Cell Longev. 2017, 9175806 (2017).","journal-title":"Oxid. Med Cell Longev."},{"key":"434_CR69","doi-asserted-by":"publisher","first-page":"8056","DOI":"10.3390\/ijms25158056","volume":"25","author":"M Campisi","year":"2024","unstructured":"Campisi, M. et al. Revealing the hidden impacts: Insights into biological aging and long-term effects in pauci- and asymptomatic COVID-19 healthcare workers. Int. J. Mol. Sci. 25, 8056 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"434_CR70","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1161\/STROKEAHA.121.037419","volume":"53","author":"C Gallego-Fabrega","year":"2022","unstructured":"Gallego-Fabrega, C. et al. Biological age acceleration is lower in women with ischemic stroke compared to men. Stroke. 53, 2320\u20132330 (2022).","journal-title":"Stroke."},{"key":"434_CR71","unstructured":"Alberts, S. C. et al. The male-female health-survival paradox: A comparative perspective on sex differences in aging and mortality. in Sociality, Hierarchy, Health: Comparative Biodemography: A Collection of Papers (National Academies Press (US), 2014)."},{"key":"434_CR72","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1183\/16000617.0121-2024","volume":"34","author":"P Tondo","year":"2025","unstructured":"Tondo, P. et al. Sex and gender differences during the lung lifespan: Unveiling a pivotal impact. Eur. Respir. Rev. 34, 175 (2025).","journal-title":"Eur. Respir. Rev."},{"key":"434_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00414-017-1636-0","volume":"132","author":"M Sp\u00f3lnicka","year":"2018","unstructured":"Sp\u00f3lnicka, M. et al. DNA methylation in ELOVL2 and C1orf132 correctly predicted chronological age of individuals from three disease groups. Int J. Leg. Med. 132, 1\u201311 (2018).","journal-title":"Int J. Leg. Med."},{"key":"434_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0257-7","volume":"8","author":"M Sp\u00f3lnicka","year":"2016","unstructured":"Sp\u00f3lnicka, M. et al. Donor age and C1orf132\/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation. Clin. Epigen. 8, 93 (2016).","journal-title":"Clin. Epigen."},{"key":"434_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r24","volume":"15","author":"CI Weidner","year":"2014","unstructured":"Weidner, C. I. et al. Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol. 15, R24 (2014).","journal-title":"Genome Biol."},{"key":"434_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0186-5","volume":"8","author":"LP Breitling","year":"2016","unstructured":"Breitling, L. P. et al. Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin. Epigen. 8, 21 (2016).","journal-title":"Clin. Epigen."},{"key":"434_CR77","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S2213-2600(17)30387-9","volume":"5","author":"RJ Allen","year":"2017","unstructured":"Allen, R. J. et al. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir. Med. 5, 869\u2013880 (2017).","journal-title":"Lancet Respir. Med."},{"key":"434_CR78","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1164\/rccm.201905-1017OC","volume":"201","author":"RJ Allen","year":"2020","unstructured":"Allen, R. J. et al. Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 201, 564\u2013574 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR79","doi-asserted-by":"publisher","unstructured":"Allen, R. J. et al. Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-218577 (2022).","DOI":"10.1136\/thoraxjnl-2021-218577"},{"key":"434_CR80","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","volume":"1","author":"I Noth","year":"2013","unstructured":"Noth, I. et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: A genome-wide association study. Lancet Respir. Med. 1, 309\u2013317 (2013).","journal-title":"Lancet Respir. Med."},{"key":"434_CR81","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1164\/rccm.202205-0845OC","volume":"207","author":"JM Oldham","year":"2023","unstructured":"Oldham, J. M. et al. PCSK6 and survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 207, 1515\u20131524 (2023).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR82","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12931-021-01694-z","volume":"22","author":"D Biondini","year":"2021","unstructured":"Biondini, D. et al. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment. Respir. Res. 22, 98 (2021).","journal-title":"Respir. Res."},{"key":"434_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00408-025-00837-z","volume":"203","author":"JJ van der Vis","year":"2025","unstructured":"van der Vis, J. J. et al. Stratifying GAP stages by MUC5B rs35705950 T-allele carriage refines survival prediction in IPF. Lung. 203, 85 (2025).","journal-title":"Lung."},{"key":"434_CR84","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1152\/physrev.00004.2016","volume":"96","author":"CM Evans","year":"2016","unstructured":"Evans, C. M. et al. Idiopathic pulmonary fibrosis: A genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol. Rev. 96, 1567\u20131591 (2016).","journal-title":"Physiol. Rev."},{"key":"434_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07768-9","volume":"9","author":"LA Hancock","year":"2018","unstructured":"Hancock, L. A. et al. Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice. Nat. Commun. 9, 5363 (2018).","journal-title":"Nat. Commun."},{"key":"434_CR86","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/thoraxjnl-2019-213738","volume":"76","author":"KL Bradley","year":"2021","unstructured":"Bradley, K. L., Stokes, C. A., Marciniak, S. J., Parker, L. C. & Condliffe, A. M. Role of unfolded proteins in lung disease. Thorax. 76, 92\u201399 (2021).","journal-title":"Thorax."},{"key":"434_CR87","doi-asserted-by":"publisher","unstructured":"Ma, X. et al. Endoplasmic reticulum stress in MUC5B-driven lung fibrosis. In TP107. TP107 PULMONARY FIBROSIS: MOLECULAR AND CELLULAR MECHANISMS A4216\u2013A4216 (American Thoracic Society, 2021). https:\/\/doi.org\/10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A4216.","DOI":"10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A4216"},{"key":"434_CR88","first-page":"A6354","volume":"197","author":"E Dobrinskikh","year":"2018","unstructured":"Dobrinskikh, E., Walts, A. D. & Schwartz, D. A. MUC5B expression in IPF is associated with ER stress. Am. J. Respir. Crit. Care Med. 197, A6354 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR89","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/jama.2013.5827","volume":"309","author":"AL Peljto","year":"2013","unstructured":"Peljto, A. L. et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA. 309, 2232\u20132239 (2013).","journal-title":"JAMA."},{"key":"434_CR90","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold, M. A. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364, 1503\u20131512 (2011).","journal-title":"N. Engl. J. Med."},{"key":"434_CR91","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S2213-2600(18)30135-8","volume":"6","author":"A Dressen","year":"2018","unstructured":"Dressen, A. et al. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. Lancet Respir. Med. 6, 603\u2013614 (2018).","journal-title":"Lancet Respir. Med."},{"key":"434_CR92","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1513\/AnnalsATS.201503-110AW","volume":"12","author":"IV Yang","year":"2015","unstructured":"Yang, I. V., Fingerlin, T. E., Evans, C. M., Schwarz, M. I. & Schwartz, D. A. MUC5B and idiopathic pulmonary fibrosis. Ann. ATS. 12, S193\u2013S199 (2015).","journal-title":"Ann. ATS."},{"key":"434_CR93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/0-387-32824-6_7","volume":"575","author":"DMT Yu","year":"2006","unstructured":"Yu, D. M. T., Wang, X. M., Ajami, K., McCaughan, G. W. & Gorrell, M. D. DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. Adv. Exp. Med Biol. 575, 63\u201372 (2006).","journal-title":"Adv. Exp. Med Biol."},{"key":"434_CR94","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 205, e18\u2013e47 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR95","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","volume":"37","author":"RM Cawthon","year":"2009","unstructured":"Cawthon, R. M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 37, e21 (2009).","journal-title":"Nucleic Acids Res"},{"key":"434_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-020-00669-9","volume":"19","author":"S Pavanello","year":"2020","unstructured":"Pavanello, S., Campisi, M., Mastrangelo, G., Hoxha, M. & Bollati, V. The effects of everyday-life exposure to polycyclic aromatic hydrocarbons on biological age indicators. Environ. Health 19, 128 (2020).","journal-title":"Environ. Health"},{"key":"434_CR97","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202505-1202RL","author":"J Zhu","year":"2025","unstructured":"Zhu, J., Zhou, D., Chen, Y., You, Z. & Li, Y. Plasma proteomic biomarkers underlying polygenic risk of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. https:\/\/doi.org\/10.1164\/rccm.202505-1202RL (2025).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"434_CR98","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12890-025-03836-1","volume":"25","author":"N Golchin","year":"2025","unstructured":"Golchin, N. et al. Incidence and prevalence of idiopathic pulmonary fibrosis: A systematic literature review and meta-analysis. BMC Pulm. Med. 25, 378 (2025).","journal-title":"BMC Pulm. Med."}],"container-title":["npj Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-026-00434-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-026-00434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-026-00434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:02:54Z","timestamp":1794445374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-026-00434-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1038\/s41514-026-00434-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7686711\/v1","asserted-by":"object"}]},"ISSN":["2731-6068"],"issn-type":[{"value":"2731-6068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.S. reports consulting fees from Novartis and PPM Services, honoraria for lectures from Boehringer-Ingelheim, honoraria for participation to advisory board from AstraZeneca, BMS, Trevi, Merck, Novartis, and Structure Therapeutics, support for attending meetings from PPM Services, and institutional grants from Roche, Boehringer-Ingelheim, Chiesi, and PPM Services. His wife is an employee of AstraZeneca. E.B. reports honoraria for lectures and for participation to advisory boards from Boehringer-Ingelheim and Roche. F.T. is an employee of the SNP genotyping department at BMR Genomics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"154"}}